Stay updated on Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.

Latest updates to the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page
- ChecktodayChange DetectedThe page’s displayed software/site revision was updated from v3.5.2 to v3.5.3, indicating a minor ClinicalTrials.gov platform update without altering the study information.SummaryDifference0.1%

- Check8 days agoChange DetectedA minor version update was applied to the page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check36 days agoChange DetectedSite revision label updated from v3.4.3 to v3.5.0. This appears to be a UI/version update and does not affect trial data.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the site.SummaryDifference0.1%

- Check72 days agoChange DetectedThe new platform revision is visible as Revision: v3.4.2, replacing v3.4.1. Study content and page details appear unchanged.SummaryDifference0.1%

- Check79 days agoChange DetectedMinor revision update from v3.4.0 to v3.4.1; no changes to study details or content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.